The function of rho factor in transcription termination depends on interactions with nascent RNA molecules that contain unpaired cytldylate residues. We show that cytidine, as a free nucleoside, inhibits the binding of rho to X cro mRNA and is a competitive inhibitor of rhoATPase activity with X cro mRNA as cofactor. The relative ability of various cytidine analogs and other nucteosldes to inhibit the rho-RNA interaction was used to probe features responsible for the base specificity of rho action. The results suggest that rho has a specificity pocket in its polynucleotide-blnding site that apparently can make H-oond interactions with the side of the cytosine ring that normally faces away from the sugar ring and that may involve a relatively close fit along the edge of the ribose ring at the (V carbon. The nature of the complex of rho with cytidine nucleotides was analyzed further by determining whether incubation with BrCMP caused inactivatlon of rho ATPase. Although BrCMP could form Michaelis inhibition complexes, it did not activate rho. Rho thus lacks a diagnostic property of enzymes that make specific covalent addition complexes with pyrimldines.
INTRODUCTION
Transcription termination factor rho from Escherichia coli mediates release of RNA from transcription complexes (1) in a reaction process that is initiated by the binding of rho to the nascent RNA and is driven by the hydrolysis of ATP (2) (3) (4) (5) (6) . Rho protein also catalyzes hydrolysis of ATP with free, isolated RNA transcripts as cofactors (7, 8) . Since the termination and rho-ATPase activities have the same dependence on RNA sequence and structure and the same sensitivities to reaction conditions, the ATP hydrolysis reaction with free RNA serves as a convenient monitor for mechanistic studies of rho action on nascent transcripts.
One of the requirements for activation of rho ATPase is the presence of unpaired cytidylate (C) residues in the RNA cofactor (9) . RNA molecules lacking C residues have virtually no cofactor activity, while poly(C) and synthetic copolymers of U and C containing as few as one C residue out of 20 are very potent activators. These requirements suggest that rho protein may have a site or set of sites that can interact directly with C residues. Since rho binds to poly(Q with high affinity even in the presence of high concentrations of monovalent counterions (i.e., 2M KC1), the interactions in a putative C-specific site are likely to involve non-ionic bonds with the base and sugar components of a C residue (10) . Hence, such a site could bind cytidine directly as a free nucleoside.
We report here evidence for the interaction between rho and cytidine and characterize some of the features responsible for the specificity of its binding site from the ability of various cytidine analogs to reproduce the action of cytidine. The results indicate that determinants on the C 2 -N 4 -C 4 side of the cytosine base and on the C 2 ' of the ribose group are important in the binding of RNA to rho.
MATERIALS AND METHODS

Biochemkals and enzymes
Nucleoside triphosphates were purchased from Boehringer Mannheim Corp. [a-^PJUTP (3200 Ci/nmol) and [a-^PJATP (650 Ci/nmol) were obtained from ICN Chemical and Radioisotope Division. All other nucleosides and nucleotides were purchased from Sigma Chemical Co. Rho protein was isolated from AR120(p39-AS) as described by Mott et at (11) . T7 RNA polymerase was isolated from BL21(pAR1219) (12) by the procedure of Tabor and Richardson (13) .
RNAs
The methods for synthesis and purification of X cro RNA are described in Faus and Richardson (8) . The RNA in all cases was transcribed from pIF2 DNA that had been digested with Taql; it thus consists of a transcript of the cro gene to nucleotide 378.
ATPase assays ATP hydrolysis was measured by the release of labeled ADP from [a-32 P]ATP as follows: The standard reaction mixture with cro RNA as cofactor contained 0.34 pmol (95 ng) of rho and 0.54 pmol (68 ng) of cro RNA in 20 /il of a solution
• To whom correspondence should be addressed consisting of 40 mM Tris-HCl (pH 7.9), 25 mM KC1, 1 raM MgCl 2 , 0.1 mM dithiothreitol, 0.1 mM EDTA and lmM [a- 32 P]ATP (800 cpm/nmol); it was incubated for 45 min at 37 °C. The hydrolysis of ATP by rho-RNA complexes was strictly linear for at least 60 min, as long as less than 80% of the initial amount of ATP was hydrolyzed. The 45 min time point was chosen to measure the rates, as it gives an adequate level of ATP hydrolyzed with the low level of rho used. The standard reaction mixture with poly(C) as cofactor contained 0.22 pmol (60 ng) of rho and 50 ng of poly(Q (150 pmol of CMP residues) in TKM buffer [50 mM tris-HCl (pH 8.0), 50 mM KC1, 5 mM MgCl 2 , 0.1 mM EDTA] with 1 mM [a-^P] ATP (-1,000 cpm/nmol); it was incubated for 10 min at 37 °C. For both, the reaction was quenched by addition of EDTA to 50 mM and ADP to 80 mM and a 4 /d sample was applied to a poly(ethylenimine)-cellulose strip (Brinkmann), which was then developed with 1 M formic acid-0.5 M LiCl to separate ADP from ATP. The ADP and ATP spots, located with an ultraviolet light, were cut from the strip, and the strip segments were placed in separate vials with 2 ml of a toluene-based scintillation mixture and assayed for radioactivity. 
Rho
RESULTS AND DISCUSSION
Cytidine competes with an mRNA for binding to rho Several properties of the interaction between rho and an RNA transcript have been established for X cro RNA (8, 14) . One property that correlates well with the function of rho factor in transcription termination at XtR) is the activation of rho-ATPase with isolated X cro RNA as a cofactor. Perturbation of that interaction can be analyzed readily by standard, steady-state enzyme kinetic methods. Thus, if cytidine binds to the C-specific domain of the RNA binding site, it should act as a competitive inhibitor of RNA cofactor function in activation of ATP hydrolysis. Figure 1 shows the effects of cytidine and of undine on rho-ATPase with X cro RNA as a cofactor in slight stoichiometric excess over rho hexamer. In the absence of cytidine, rho catalyzed the hydrolysis of ATP at a rate of 650 molecules-min" 1 per rho hexamer (2.3 nmol-min~1-/ig~1)-That rate was reduced by 50% and 80% with 20 mM and 100 mM cytidine, respectively, but was reduced by less than 5% with 100 mM uridine. Thus between these two pyrimidine nucleosides, inhibition was selective for cytidine. To test whether inhibition is competitive with X cro RNA, rates of ATP hydrolysis without or with 30 mM cytidine present were measured at various concentrations of X cro RNA and the data analyzed on a double reciprocal plot. The results ( Figure 2 ) show that the rates of hydrolysis, as indicated by the values of 1/v, were the same in using the values of V^, and Km determined in Figure 2 . The Kj determined from this best fit was 11.1 ± 0.6 mM, which is in good agreement with the Kj determined independently in Figure 2 . The inhibition of the interaction between rho and X cro RNA can also be detected with direct binding assays. The assays we used measure the retention of labeled X cro RNA with rho protein on membrane filters (8, 14) . With a limiting amount of RNA (0.21 nM), the presence of 0.35 nM rho caused 63% of the labeled X cro RNA to be retained on the filter with our standard conditions in the absence of cytidine. However, in the presence of 20 mM cytidine, the amount of RNA retained was half that value (Table  1) . Thus, the results of the direct RNA binding assays confirm those of the ATPase inhibition studies.
Although the inhibition with cytidine is specific and competitive with RNA, it is relatively weak; the K; for cytidine is about 10 6 fold higher than the kj for the rho-cro RNA interactions. However, this difference is reasonable considering that the RNA site within a single subunit of rho likely consists of a relatively large surface that can make multiple contacts with several residues on a single RNA molecule with the cytidine specificity pocket being only part of that surface. Thus, the RNA molecule presumably forms a large number of weak bonds over several subunits in the hexameric rho protein, whereas a single cytidine molecule binds only to a part of the binding surface on a single subunit.
Since the action of rho in termination is dependent upon its binding to sites on the nascent transcript, we tested whether cytidine could inhibit rho action at tR|, the terminator for X cro RNA. However, the addition of 20 mM cytidine had no effect on normal rho action during transcription in vitro of a Hinf I-X DNA fragment containing the sequences of P R and tR] (data not shown). One possible explanation for this negative result is that rho may be interacting with the RNA as part of a preformed complex with RNA polymerase in the transcription complex. In this case, the binding of the nascent RNA will be quasiunimolecular, and the local concentration of the nascent RNA in the domain of rho factor bound to RNA polymerase would be effectively much higher than that of free RNA at the same overall concentration. Since the binding of cytidine is competitive with RNA, a higher effective concentration would allow the RNA to compete better. The limitation on the solubility of cytidine precluded testing a much higher concentration.
Inhibition with cytidine analogs
Because of its simplicity, the direct binding assay can be used to screen a large number of cytidine analogs and other nucleosides for their effectiveness in inhibiting the binding of rho to X cro RNA. The differences in effectiveness can then be correlated with the structural change in the nucleoside to delineate the features of the cytidine residues that are responsible for the binding interaction. The results (Table 1) indicate that functional groups on both the pyrimidine ring and the sugar ring contribute to the effectiveness of cytidine as an inhibitor. Figure 3 shows a perspective drawing of cytidine that is based on its crystal structure (15) . We use this structure to formulate a working model of the possible disposition of functional groups that are responsible for the binding of cytidine residues in rho's RNA binding site. In agreement with the ATPase assay results, uridine did not inhibit binding of rho to cro RNA (Table 1 ). This suggests that binding specificity is determined by having a good H-bond donor group on position 4 or an H-bond acceptor at position 3 (the imino N) or both. The finding that N,N-dimethyl-2'-deoxycytidine failed to give significant inhibition (the 2' hydroxyl group is not a specificity determinant, as noted below) indicates that an H-bond donor group on position 4 is a critical element.
Another change on the pyrimidine ring that greatly affected competition was replacement of the oxygen at C 2 with S; 2-thiocytidine had negligible inhibition when tested at the limit of its solubility (Table 1) . This chemical change has several consequences (16): the van der Waals radius is somewhat larger for S than for 0 (1.85 A vs. 1.4 A); S is a poorer H-bond acceptor than is O, and the C=S double bond is about 0.4A longer than is the C=O double bond. Any or all of these could contribute to a poorer fit and/or weaker bonding interactions. In a crystal, the pyrimidine base in cytidine has the a/tfi-orientation, as shown in Fig. 3 . Assuming die orientation is the same in solution, the functional groups at C 2 and C 4 would likely fit into a cleft diat would be the deepest part of the putative cytidine specificity site. The facts that the C 5 could be replaced by N, as in azacytidine, and the H on C 5 by a Br widi relatively small effects on the binding (Table 1) are consistent with the interpretation that the H-bonding in the cleft is the major region of interaction with die pyrimidine base.
Binding of die nucleoside clearly involves contacts widi the sugar ring as well. This was indicated in a gross sense by die fact that an analog widi cytosine attached in the wrong anomeric conformation had no inhibitory activity (a-cytidine). However, even with analogs that have the normal /3-anomeric conformation, binding inhibition was sensitive to die nature and orientation of groups about the C 2 of the ribose ring. The finding that 2'-deoxycytidine was a more potent inhibitor than was cytidine implies that die 2'-OH group is not essential and may even be a partial hindrance. This apparently higher affinity for deoxycytidine tiian for cytidine is interesting because widi polynucleotides rho does not show a preference for DNA over RNA; it binds as well to poly(rC) as to poly(dC) (17) and may even have a slight preference for poly(rC) (10) . This lack of DNA preference at die polynucleotide level may be reflecting the contributions of odier parts of die polynucleotide binding site on rho, besides die cytidine pocket. Rho contains some sequence segments with identities and similarities to consensus sequences in RNA binding proteins (18) and diese may comprise diose parts of the binding site that are responsible for die RNA preference at die polynucleotide level.
In cytidine, die 2'-OH group has an axial orientation and is on the opposite side of die ribose ring as die pyrimidine base (Figure 3 ). In arabinosylcytosine, die 2'-OH group is on the same side as the base and also with an axial orientation (19) . Since this analog had moderate competitive activity, the site can accommodate the presence of an OH group widi die opposite orientation. However, 2'-O-metiiylcytidine was virtually ineffective as a competitor. In its crystal structure, the orientation of die C 2 '-O bond is equatorial (20) . Thus, a likely reason for its lack of inhibition is an inability to fit into the site because of steric hindrance. We propose diat rho protein makes a close van der Waals contact widi die edge of the ribose ring at die C 2 ' position. Since poly(2'-O-metiiylcytidylate) does not compete widi poly(C) for binding to rho whereas poly(dQ does (10), die proposed van der Waals contact appears to be a characteristic of die binding specificity with polynucleotides as widi nucleosides.
The C-specific site also appears to be characterized by a strict steric relation between die cleft for die heterocyclic aromatic ring and die positioning groups for die ribose ring. This is suggested by die lack of inhibitory activity of adenosine, which, because of its amino group, might be able to bind into the cleft, but, because of die larger size of die purine ring, would not allow simultaneous contact widi functional groups on die ribose ring system.
Anodier unexpected finding was diat none of die nucleotide derivatives of cytidine (5', 3' or 2'-CMP) were agnificandy better or worse competitors dian was cytidine (Table 1) . This was unexpected because ionic bonds are important in stabilizing the interaction of rho widi mRNA (8) , and it is assumed diat basic residues comprise some portion of the polynucleotide binding site. This result suggests that diese basic residues are not in very close proximity to die cytidine binding pocket. This would also explain why, unlike its interaction with natural mRNA molecules, rho can bind tightiy to poly(C) even in 2M KC1 (10) . The fact that 3'-CMP was a slightiy better inhibitor of binding dian was cytidine while 5'-CMP was not suggests diat a basic residue may be situated close enough to the side of die ribose binding pocket that accommodates die 3'-phosphate group to make a weak, added bonding interaction. The finding that 2'-CMP was the weakest inhibitor in this group is consistent widi die evidence that nucleoside binding was sensitive to odier 2' substitutions. Finally, it is notable that 3'-O-mediylcytidine, unlike 2'-O-metiiylcytidine, was a moderately effective competitor. This result is a further indication diat the steric constraints diat apply to the 2' position do not apply to die 3' position.
Test for possible covalent adduct
One known mechanism for binding of pyrimidine nucleotides to proteins involves the reversible addition of a nucleophilic group to C 6 of me pyrimidine ring (21) . A diagnostic property of this kind of reaction is that the addition products with 5-Br pyrimidine analogs often form dead-end products diat inactivate die enzyme (22, 23) . To test whemer a nucleophilic addition is involved in the binding of rho to C residues in RNA, we measured the effect of a 5-bromocytidine derivative on rho-ATPase activity. For dus study, we used 5-bromocytidine 5'-monophosphate (BrCMP), which binds tightly enough to rho to inhibit ATPase widi poly(Q. When BrCMP was present at 50 mM during die assay, rho ATPase was inhibited by 50% (Figure 4) . However, when it was present at that concentration during preincubation with 0.3 mg/ml rho and diluted 100-fold prior to performing the ATPase assays, full activity was recovered throughout the range of preincubation times tested (Figure 4) . Thus, even though BrCMP evidently forms a Michaelis complex with rho, it does not readily form a dead-end reaction product. In this respect, rho is unlike several other enzymes that are known to bind to pyrimidine nucleotides.
The possibility that formation of a nucleophilic adduct might be a critical step in rho action was first raised because wild type rho has a single cysteine and is sensitive to reagents that react readily with cysteine residues. However, Dombroski and Platt (24) showed that a mutant derivative of rho with the cysteine residue replaced by an alanine was fully active, and Seifried et al. (25) showed that the cysteine in wild-type rho could be alkylated without significantly changing rho's functional properties. Thus, the cysteine residue is not essential for rho action. Our results extend those findings because inactivation with BrCMP might have then pointed to the involvement of some other nucleophilic group. Although the possibility that some other residue in rho forms an adduct with cytidine has not been formally eliminated, that hypothesis can now be considered unlikely because of the lack of formation of the diagnostic dead-end reaction product with BrCMP.
